MedPath

Bright light therapy for delayed sleep phase syndrome in children with ADHD.

Phase 3
Withdrawn
Conditions
inslaapstoornissen (vertraagd slaap fase syndroom)
sleep onset insomnia
sleep onset problems.
Registration Number
NL-OMON37624
Lead Sponsor
niversiteit Leiden
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
Not specified
Target Recruitment
50
Inclusion Criteria

ages 7-12 years (elementary school

Exclusion Criteria

1) sleep disturbances other than delayed sleep phase syndrome that can lead to chronic problems falling asleep (e.g. sleep apnea, period limb movement disorder, psychophysiological insomnia). 2) epilepy 3) chronic pain 4) mental retardation 5) (suspicion of) significant neuropathology (e.g. genetic syndromes, acquired brain injury) 6) use of melatonin. When children are stable on ADHD treatment they are allowed to participate.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Mean sleep onset and sleep duration (actigraphy) during baseline, 1st treatment<br /><br>phase and second phase.<br /><br>Score on behavioral questionnaire during baseline, 1st treatment phase and<br /><br>second phase.<br /><br>Scores on neurocognitive tasks during baseline, 1st treatment phase and second<br /><br>phase. </p><br>
Secondary Outcome Measures
NameTimeMethod
<p>-</p><br>
© Copyright 2025. All Rights Reserved by MedPath